Mélanie Masse

431 total citations
9 papers, 174 citations indexed

About

Mélanie Masse is a scholar working on Surgery, Transplantation and Molecular Biology. According to data from OpenAlex, Mélanie Masse has authored 9 papers receiving a total of 174 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 3 papers in Transplantation and 2 papers in Molecular Biology. Recurrent topics in Mélanie Masse's work include Renal Transplantation Outcomes and Treatments (3 papers), Organ Transplantation Techniques and Outcomes (3 papers) and Cell death mechanisms and regulation (2 papers). Mélanie Masse is often cited by papers focused on Renal Transplantation Outcomes and Treatments (3 papers), Organ Transplantation Techniques and Outcomes (3 papers) and Cell death mechanisms and regulation (2 papers). Mélanie Masse collaborates with scholars based in Canada and Gabon. Mélanie Masse's co-authors include Marie‐Josée Hébert, Isabelle Sirois, Stéphan Troyanov, Normand Vigneault, François Madore, Anne Boucher, Isabelle Houde, Héloïse Cardinal, Dana Baran and Elham Rahme and has published in prestigious journals such as Kidney International, The American Journal of Medicine and American Journal of Kidney Diseases.

In The Last Decade

Mélanie Masse

7 papers receiving 168 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mélanie Masse Canada	6	64	58	40	38	37	9	174
Mythili Ghanta United States	8	80 1.3×	93 1.6×	43 1.1×	134 3.5×	33 0.9×	13	301
Misao Niwa Japan	5	80 1.3×	77 1.3×	54 1.4×	44 1.2×	8 0.2×	5	240
G Senatorski Poland	9	71 1.1×	84 1.4×	34 0.8×	16 0.4×	9 0.2×	22	190
Bum-Soon Choi South Korea	6	46 0.7×	66 1.1×	24 0.6×	41 1.1×	11 0.3×	13	186
Serhat Aytug United States	6	55 0.9×	41 0.7×	37 0.9×	17 0.4×	7 0.2×	7	337
Diba Emal Netherlands	6	41 0.6×	20 0.3×	103 2.6×	102 2.7×	14 0.4×	7	310
Mangalee Fernando Australia	7	31 0.5×	30 0.5×	52 1.3×	58 1.5×	5 0.1×	9	134
Ayşegül Oruç Türkiye	8	21 0.3×	11 0.2×	40 1.0×	75 2.0×	11 0.3×	40	151
S Todo United States	10	318 5.0×	51 0.9×	18 0.5×	6 0.2×	52 1.4×	22	390
C. Levi France	7	19 0.3×	11 0.2×	41 1.0×	37 1.0×	11 0.3×	13	137

Countries citing papers authored by Mélanie Masse

Since Specialization

Citations

This map shows the geographic impact of Mélanie Masse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Masse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Masse more than expected).

Fields of papers citing papers by Mélanie Masse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Masse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Masse. The network helps show where Mélanie Masse may publish in the future.

Co-authorship network of co-authors of Mélanie Masse

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Masse. A scholar is included among the top collaborators of Mélanie Masse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Masse. Mélanie Masse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Lemieux, Pierre, et al.. (2024). Immune checkpoint inhibitors and risk of immune-mediated adverse events: a cohort study comparing extended versus standard interval administration. Clinical and Experimental Medicine. 24(1). 40–40.

2.

Baran, Dana, Anne Boucher, Isabelle Houde, et al.. (2022). Factors Associated With the Use of Hypothermic Machine Perfusion in Kidney Transplant Recipients: A Multicenter Retrospective Cohort Study. Canadian Journal of Kidney Health and Disease. 9. 1015003538–1015003538.

3.

Cardinal, Héloïse, A. Lagacé, Martin Albert, et al.. (2018). Organ donor management and delayed graft function in kidney transplant recipients: A multicenter retrospective cohort study. American Journal of Transplantation. 19(1). 277–284. 27 indexed citations

4.

Allard, Catherine, et al.. (2015). Trichodysplasia Spinulosa in a Renal Transplant Patient. Journal of Cutaneous Medicine and Surgery. 19(1). 66–68. 8 indexed citations

5.

Masse, Mélanie, et al.. (2010). A Case of Hypercalcemia and Scabies. The American Journal of Medicine. 123(4). e5–e6. 1 indexed citations

6.

Cardinal, Héloïse, Marie‐Josée Hébert, Elham Rahme, et al.. (2005). Modifiable factors predicting patient survival in elderly kidney transplant recipients. Kidney International. 68(1). 345–351. 45 indexed citations

7.

Troyanov, Stéphan, Marie‐Josée Hébert, Mélanie Masse, et al.. (2003). Soluble Fas: a novel predictor of atherosclerosis in dialysis patients. American Journal of Kidney Diseases. 41(5). 1043–1051. 47 indexed citations

8.

Masse, Mélanie, Marie‐Josée Hébert, Stéphan Troyanov, et al.. (2002). Soluble Fas is a marker of peripheral arterial occlusive disease in haemodialysis patients. Nephrology Dialysis Transplantation. 17(3). 485–491. 18 indexed citations

9.

Hébert, Marie‐Josée, Mélanie Masse, Normand Vigneault, et al.. (2001). Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease. American Journal of Kidney Diseases. 38(6). 1271–1276. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact